Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Vitiligo [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating umbilical cord mesenchymal stem cell-derived exosomes for vitiligo; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes (exosomes)

Snippet

Sponsor: Xijing Hospital | Conditions: Vitiligo, Mesenchymal Stem Cells | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING